MEDA Ventures is a US healthcare venture capital group investing in privately-held US and foreign-based companies in therapeutics, medical devices and digital health. We are a physician- and scientist-founded group targeting high impact and high return on investment opportunities.

Developer of an innovative clinical trial insurance and funding vehicle: For investments in therapeutics companies, MEDA Partners have developed a highly unique clinical trial insurance and funding vehicle launched by Lloyd’s of London and other lenders & investors. MEDA Ventures will potentially invest alongside this vehicle capitalizing on the extensive underwriting performed for Lloyd's insurance coverage through the use of an AI predictive platform of GATC Health. A third party and double-blind evaluation of this platform has shown a much higher hit rate of identifying successful drugs than historical success rates in trials.